These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25650304)

  • 21. Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: a meta-analysis.
    Miao RY; Zhao HT; Yang HY; Mao YL; Lu X; Zhao Y; Liu CN; Zhong SX; Sang XT; Huang JF
    World J Gastroenterol; 2010 Jun; 16(23):2931-42. PubMed ID: 20556841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The comparison of different antiviral therapies on the prognosis of hepatitis B virus-related hepatocellular carcinoma after curative treatments: A network meta-analysis.
    Xia Z; He L; Xiong L; Wen T
    Medicine (Baltimore); 2020 Aug; 99(33):e20877. PubMed ID: 32871973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral therapy and long-term outcome for hepatitis B virus-related hepatocellular carcinoma after curative liver resection in a Japanese cohort.
    Sakamoto K; Beppu T; Hayashi H; Nakagawa S; Okabe H; Nitta H; Imai K; Hashimoto D; Chikamoto A; Isiko T; Kikuchi K; Baba H
    Anticancer Res; 2015 Mar; 35(3):1647-55. PubMed ID: 25750323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Nucleot(s)ide Analogs Therapy in Patients with Unresectable HBV-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    He L; Liu X; Zhao Y; Zhang S; Jiang Y; Wang X; Yang Z
    Dis Markers; 2017; 2017():7075935. PubMed ID: 28396612
    [No Abstract]   [Full Text] [Related]  

  • 25. How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma?
    Wang CC; Kao JH
    Expert Opin Pharmacother; 2016; 17(7):911-9. PubMed ID: 26831361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of adjuvant antiviral therapy with risk of cancer progression and deaths in patients with hepatitis-B-virus-related hepatocellular carcinoma following curative treatment: a nationwide cohort study.
    Yeh YC; Liu CJ; Kuo RN; Lai CL; Shau WY; Chen PJ; Lai MS
    PLoS One; 2014; 9(7):e102051. PubMed ID: 25025231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A long-term study of the effects of antiviral therapy on survival of patients with HBV-associated hepatocellular carcinoma (HCC) following local tumor ablation.
    Hann HW; Coben R; Brown D; Needleman L; Rosato E; Min A; Hann RS; Park KB; Dunn S; DiMarino AJ
    Cancer Med; 2014 Apr; 3(2):390-6. PubMed ID: 24519810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis B.
    Kawaguchi K; Honda M; Ohta H; Terashima T; Shimakami T; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Komura T; Unoura M; Kaneko S
    J Gastroenterol; 2018 Jun; 53(6):740-751. PubMed ID: 28849280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma.
    Wong JS; Wong GL; Tsoi KK; Wong VW; Cheung SY; Chong CN; Wong J; Lee KF; Lai PB; Chan HL
    Aliment Pharmacol Ther; 2011 May; 33(10):1104-12. PubMed ID: 21488914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma.
    Kuzuya T; Katano Y; Kumada T; Toyoda H; Nakano I; Hirooka Y; Itoh A; Ishigami M; Hayashi K; Honda T; Goto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1929-35. PubMed ID: 17914972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma.
    Chan AC; Chok KS; Yuen WK; Chan SC; Poon RT; Lo CM; Fan ST
    Arch Surg; 2011 Jun; 146(6):675-81. PubMed ID: 21690443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
    Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
    Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.
    Viganò M; Bhoori S; Lampertico P; Donato MF; Iavarone M; Grossi G; Facciorusso A; Caccamo L; Rossi G; Colombo M; Mazzaferro V
    Liver Int; 2015 Sep; 35(9):2187-93. PubMed ID: 25809541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib.
    Yang Y; Wen F; Li J; Zhang P; Yan W; Hao P; Xia F; Bi F; Li Q
    Liver Int; 2015 Sep; 35(9):2147-54. PubMed ID: 25676812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of Preoperative Antiviral Treatment of Patients with HCC Negative for HBV-DNA.
    Liu XF; Zhang T; Tang K; Sui LL; Xu G; Liu Q
    Anticancer Res; 2017 Aug; 37(8):4701-4706. PubMed ID: 28739774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.
    Yang T; Lu JH; Zhai J; Lin C; Yang GS; Zhao RH; Shen F; Wu MC
    Eur J Surg Oncol; 2012 Aug; 38(8):683-91. PubMed ID: 22621971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B-related hepatocellular carcinoma.
    Wong GL; Tse YK; Chan HL; Yip TC; Tsoi KK; Wong VW
    Aliment Pharmacol Ther; 2016 Apr; 43(7):802-13. PubMed ID: 26843444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative therapy options for hepatocellular carcinoma.
    Zhong JH; Ma L; Li LQ
    Scand J Gastroenterol; 2014 Jun; 49(6):649-61. PubMed ID: 24716523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach.
    Shen YC; Hsu C; Chen LT; Cheng CC; Hu FC; Cheng AL
    J Hepatol; 2010 Jun; 52(6):889-94. PubMed ID: 20395009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transarterial chemoembolization for hepatitis B virus-associated hepatocellular carcinoma: improved survival after concomitant treatment with nucleoside analogues.
    Toyoda H; Kumada T; Tada T; Sone Y; Fujimori M
    J Vasc Interv Radiol; 2012 Mar; 23(3):317-22.e1. PubMed ID: 22265248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.